Clare Kirwan1, John M Nolan2, Jim Stack2, Ian Dooley3, Johnny Moore4, Tara Cb Moore4, Stephen Beatty5. 1. Biomedical Science Research Institute, University of Ulster, Coleraine, Northern Ireland; Institute of Eye Surgery, and Institute of Vision Research, Whitfield Clinic, Cork Road, Waterford, Ireland; Macular Pigment Research Group, Waterford Institute of Technology, Waterford, Ireland. 2. Macular Pigment Research Group, Waterford Institute of Technology, Waterford, Ireland. 3. University College Hospital Limerick, Ireland. 4. Biomedical Science Research Institute, University of Ulster, Coleraine, Northern Ireland. 5. Institute of Eye Surgery, and Institute of Vision Research, Whitfield Clinic, Cork Road, Waterford, Ireland; Macular Pigment Research Group, Waterford Institute of Technology, Waterford, Ireland.
Abstract
AIM: To identify challenges inherent in introducing a toric intraocular lens (IOL) to a non-refractive cataract practice, and evaluate residual astigmatism achieved and its impact on patient satisfaction. METHODS: Following introduction of a toric IOL to a cataract practice with all procedures undertaken by a single, non-refractive, surgeon (SB), pre-operative, intra-operative and post-operative data was analysed. Attenuation of anticipated post-operative astigmatism was examined, and subjectively perceived visual functioning was assessed using validated questionnaires. RESULTS: Median difference vector (DV, the induced astigmatic change [by magnitude and axis] that would enable the initial surgery to achieve intended target) was 0.93D; median anticipated DV with a non-toric IOL was 2.38D. One eye exhibited 0.75D residual astigmatism, compared to 3.8D anticipated residual astigmatism with a non-toric IOL. 100% of respondents reported satisfaction of ≥ 6/10, with 37.84% of respondents entirely satisfied (10/10). 17 patients (38.63%) reported no symptoms of dysphotopsia (dysphoptosia score 0/10), only 3 respondents (6.8%) reported a clinically meaningful level of dysphotopsia (≥ 4/10). Mean post-operative NEI VF-11 score was 0.54 (+/-0.83; scale 0 - 4). CONCLUSION: Use of a toric IOL to manage astigmatism during cataract surgery results in less post-operative astigmatism than a non-toric IOL, resulting in avoidance of unacceptable post-operative astigmatism.
AIM: To identify challenges inherent in introducing a toric intraocular lens (IOL) to a non-refractive cataract practice, and evaluate residual astigmatism achieved and its impact on patient satisfaction. METHODS: Following introduction of a toric IOL to a cataract practice with all procedures undertaken by a single, non-refractive, surgeon (SB), pre-operative, intra-operative and post-operative data was analysed. Attenuation of anticipated post-operative astigmatism was examined, and subjectively perceived visual functioning was assessed using validated questionnaires. RESULTS: Median difference vector (DV, the induced astigmatic change [by magnitude and axis] that would enable the initial surgery to achieve intended target) was 0.93D; median anticipated DV with a non-toric IOL was 2.38D. One eye exhibited 0.75D residual astigmatism, compared to 3.8D anticipated residual astigmatism with a non-toric IOL. 100% of respondents reported satisfaction of ≥ 6/10, with 37.84% of respondents entirely satisfied (10/10). 17 patients (38.63%) reported no symptoms of dysphotopsia (dysphoptosia score 0/10), only 3 respondents (6.8%) reported a clinically meaningful level of dysphotopsia (≥ 4/10). Mean post-operative NEI VF-11 score was 0.54 (+/-0.83; scale 0 - 4). CONCLUSION: Use of a toric IOL to manage astigmatism during cataract surgery results in less post-operative astigmatism than a non-toric IOL, resulting in avoidance of unacceptable post-operative astigmatism.
Authors: Nienke Visser; Tos T J M Berendschot; Noël J C Bauer; Rudy M M A Nuijts Journal: Invest Ophthalmol Vis Sci Date: 2012-04-06 Impact factor: 4.799
Authors: Clare Kirwan; John M Nolan; Jim Stack; Tara C B Moore; Stephen Beatty Journal: Graefes Arch Clin Exp Ophthalmol Date: 2015-05-13 Impact factor: 3.117
Authors: Nienke Visser; Tos T J M Berendschot; Noël J C Bauer; Jessica Jurich; Oliver Kersting; Rudy M M A Nuijts Journal: J Cataract Refract Surg Date: 2011-08 Impact factor: 3.351
Authors: Ayman Saeed; Mark Guerin; Irfan Khan; Pearse Keane; Jim Stack; Patrick Hayes; Peter Tormey; Mark Mullhern; Stephen Beatty Journal: J Cataract Refract Surg Date: 2007-09 Impact factor: 3.351
Authors: Katie M Williams; Virginie J M Verhoeven; Phillippa Cumberland; Geir Bertelsen; Christian Wolfram; Gabriëlle H S Buitendijk; Albert Hofman; Cornelia M van Duijn; Johannes R Vingerling; Robert W A M Kuijpers; René Höhn; Alireza Mirshahi; Anthony P Khawaja; Robert N Luben; Maja Gran Erke; Therese von Hanno; Omar Mahroo; Ruth Hogg; Christian Gieger; Audrey Cougnard-Grégoire; Eleftherios Anastasopoulos; Alain Bron; Jean-François Dartigues; Jean-François Korobelnik; Catherine Creuzot-Garcher; Fotis Topouzis; Cécile Delcourt; Jugnoo Rahi; Thomas Meitinger; Astrid Fletcher; Paul J Foster; Norbert Pfeiffer; Caroline C W Klaver; Christopher J Hammond Journal: Eur J Epidemiol Date: 2015-03-18 Impact factor: 8.082